That there is hereby established a select investigative subcommittee of the Committee on Oversight and Reform called the Select Subcommittee on the Coronavirus Crisis (hereinafter referred to as the select subcommittee ). 2. (a) The select subcommittee shall be composed of not more than 12 Members, Delegates, or the Resident Commissioner appointed by the Speaker, of whom not more than 5 shall be appointed on the recommendation of the minority leader. The Speaker shall designate one member of the select subcommittee as its chair. Any vacancy in the select subcommittee shall be filled in the same manner as the original appointment. (b) Each member appointed to the select subcommittee shall be treated as though a member of the Committee on Oversight and Reform for purposes of the select subcommittee. 3. (a) The select subcommittee is authorized and directed to conduct a full and complete investigation and study and issue a final report to the House of its findings (and such interim reports as it may deem necessary) regarding— (1) the efficiency, effectiveness, equity, and transparency of the use of taxpayer funds and relief programs to address the coronavirus crisis, including through Federal agencies, State and local government entities, financial institutions and other private businesses, contracts, grants, loans, loan guarantees, investments, cooperative agreements, or any other means; (2) reports of waste, fraud, abuse, price gouging, profiteering, or other abusive practices related to the coronavirus crisis; (3) the implementation or effectiveness of any Federal law applied, enacted, or under consideration to address the coronavirus crisis and prepare for future pandemics; (4) preparedness for and response to the coronavirus crisis, including the planning for and implementation of testing, containment, mitigation, and surveillance activities; the acquisition, distribution, or stockpiling of protective equipment and medical supplies; and the development of vaccines and treatments